Oculis
phase a positive results in | Oculis
Company
Deck Type
Deck date
April 2023
Slide
22 of 39
Similar slides by Oculis
See diffirences between slides (animation)
SPAC
October 2022
phase a positive results in | Oculis
Related slides by other companies
BioAtla
Investor Presentation
August 2023
encouraging phase results with | BioAtla
Adagio Therapeutics
Results
June 2022
results from the phase randomized double blind placebo controlled trial to evaluate the efficacy and safety of in the treatment of ambulatory participants with mild or moderate covid stamp microbe | Adagio Therapeutics
Aeglea BioTherapeutics
Investor Presentation
July 2023
a has emerged as one of the most promising targets in both and | Aeglea BioTherapeutics
9 Meters Biopharma
Investor Presentation
September 2022
vibrant phase summary of results | 9 Meters Biopharma
Other recent decks by Oculis
See all presentations (6 decks)
Results
August 2023
Investor Presentation
July 2023
Investor Conference
June 2023
Results
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io